Buy & Sell Vertex Pharmaceuticals Incorporated (VRTX) – Vertex Pharmaceuticals Incorporated Price Today
Key Stats
- $110.59BMarket Cap
- HealthSector
- -9.82%3M Drawdown
- $105.33BEnterprise Value
- -Dividend Yield
- 7% Buy | 93% SellTrading Activity
- 104 daysTypical Hold Time
Vertex Pharmaceuticals Incorporated (VRTX) is currently valued at a market capitalization of $110.59B, with an enterprise value of $105.33B. Over the past 52 weeks, Vertex Pharmaceuticals Incorporated has traded between a low of $366.54 and a high of $499.17, highlighting its annual price range. Over the past three months, Vertex Pharmaceuticals Incorporated has recorded a drawdown of -9.82%, reflecting recent price volatility. On average, investors hold Vertex Pharmaceuticals Incorporated for approximately 104 days, indicating typical investor behavior on the platform.
About Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Most Recent News
BlackRock increases stake in Orion Corporation above 5%, signaling growing investor interest.
BlackRock, Inc. and its funds have increased their ownership in Orion Corporation to over 5% of the company's total shares as of June 10, 2026. This change was disclosed under the Finnish Securities Market Act, indicating BlackRock's growing investme...
Core AI launches HomeGPT, an AI home design app, after $5.4M funding round, but stock dips on dilution fears.
Core AI Holdings Inc. introduced HomeGPT, an AI-powered app for home design and renovation that lets users create and modify designs from a single photo. The launch follows a $5.4 million registered direct offering, which caused the stock to fall due...
China's Zhengxin Food plans $300M Hong Kong IPO despite 60% store drop in 5 years.
Zhengxin Food, known as China's 'Chicken King,' is preparing for a $300 million IPO in Hong Kong amid a significant reduction in its store count from 25,000 to 9,545 over five years. The company claims the downsizing is strategic, focusing on quality...